IMPACT THERAP-B（07630）
Yingpai Pharmaceuticals is dedicated to tdevelopment of innovative, targeted anticproprietary intellectual property rights,focus on the synthetic lethality mechanis
Progress
Subscription Opens
May 5, 2026, 06:30 AM UTC+0
Subscription Closes
May 7, 2026, 06:30 AM UTC+0
Allotment Results
May 10, 2026 UTC+0
Listed
May 12, 2026 UTC+0
Details
Offer Price
19.75-21.75HKD
Shares per Lot
--
Minimum Subscription Amount
--HKD
Market Cap
--
Shares Issued
--
Clawback Mechanism
--
Public Offer Ratio
--
Industry Sector
Biotechnology
Greenshoe
--
Sponsor
--
Prospectus
Prospectus.pdfUse of Funds
Name
Subscribed Shares/Proportion
Unlock Date
No data
Underwriters 0 in total
No data